CMDh March 2023 Meeting – Report CMDh March 2023 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh March 2023 Meeting – Report
DARWIN EU Completed First Studies and Calls for New Data Partners DARWIN EU Completed First Studies and Calls for New Data Partners DARWIN EU®, the Data Analysis and... DARWIN EU Completed First Studies and Calls for New Data Partners
New Statutory Fees For MHRA Services Introduced New Statutory Fees For MHRA Services Introduced From 1 April 2023, new fees were introduced for a range of MHRA... New Statutory Fees For MHRA Services Introduced
EMA HMPC Launches Calls for Submission of Scientific Data EMA HMPC Calls for Submission of Scientific Data The European Medicines Agency’s (EMA) Committee on Herbal Medicinal Products (HMPC) has... EMA HMPC Launches Calls for Submission of Scientific Data
One Size Doesn’t Fit All: Reimagining Medicines Information for Patients Report One Size Doesn’t Fit All: Reimagining Medicines Information for Patients Report A new report published March 2023, ‘... One Size Doesn’t Fit All: Reimagining Medicines Information for Patients Report
EMA HMPC Meeting Report – March 2023 EMA HMPC Meeting Report – March 2023 EMA’s Committee on Herbal Medicinal Products (HMPC) has published the report from their... EMA HMPC Meeting Report – March 2023
EMA Regulatory Science Strategy Mid-point Report Published EMA Regulatory Science Strategy Mid-point Report Published The EMA has published a report summarising the mid-term achievements... EMA Regulatory Science Strategy Mid-point Report Published
EMA ISG Meeting Presentations – March 2023 EMA ISG Meeting Presentations – March 2023 EMA has published the presentations from the last Industry Standing Group (ISG) meeting... EMA ISG Meeting Presentations – March 2023
MHRA Consultation Response – Proposals for Legislative Changes for Clinical Trials MHRA Consultation Response – Proposals for Legislative Changes for Clinical Trials In January 2022 MHRA launched a consultation on a... MHRA Consultation Response – Proposals for Legislative Changes for Clinical Trials
MHRA Publishes Marketing Authorisations Granted 1 – 14 March 2023 MHRA Publishes Marketing Authorisations Granted 1 – 14 March 2023 MHRA granted four OTC licences during 1-14 March 2023. Details... MHRA Publishes Marketing Authorisations Granted 1 – 14 March 2023
MHRA Reclassifies Cialis Together Tablets to a Pharmacy Medicine MHRA Reclassifies Cialis Together Tablets to a Pharmacy Medicine The Medicines and Healthcare products Regulatory Agency (MHRA) has reclassified Cialis... MHRA Reclassifies Cialis Together Tablets to a Pharmacy Medicine
MHRA Drug Safety Update – Pholcodine MHRA Drug Safety Update – Pholcodine Following a review by the MHRA, together with advice from CHM, the UK regulator... MHRA Drug Safety Update – Pholcodine
